Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in Diabetes

Midazolam is an anesthetic widely used for anxiolysis and sedation; however, to date, a possible role for midazolam in diabetic kidney disease remains unknown. Here, we investigated the effect of midazolam on hyperglycemia-induced glomerular endothelial dysfunction and elucidated its mechanism of ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Jae-Ah, Sayyed, Nilofar Danishmalik, Lee, Yeon-Ju, Jeon, Hye-Yoon, Kim, Eun-Bin, Hong, Seok-Ho, Cho, Soyeon, Kim, Minsoo, Ha, Kwon-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775471/
https://www.ncbi.nlm.nih.gov/pubmed/35054938
http://dx.doi.org/10.3390/ijms23020753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775471/
https://www.ncbi.nlm.nih.gov/pubmed/35054938
http://dx.doi.org/10.3390/ijms23020753

Ejemplares similares